Fresenius Medical Care AG & Co KGaA ADR sell UBS Group AG
Start price
15.10.25
/
50%
€22.40
Target price
15.10.26
-
Performance (%)
-12.95%
Price
11.12.25
€19.50
Summary
This prediction is currently active. The prediction for Fresenius Medical Care AG & Co KGaA ADR shows a convincing performance of -12.95%. This prediction currently runs until 15.10.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | -1.015% | -1.015% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by UBS_Group_AG for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ADR diskutieren
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at UBS Group AG from a "sell" rating to an "underperform" rating.
Ratings data for FMS provided by MarketBeat
Stopped prediction by UBS_Group_AG for Fresenius Medical Care AG & Co KGaA ADR
Fresenius Medical Care AG & Co KGaA ADR
Start price
Target price
Perf. (%)
€20.60
02.09.25
02.09.25
-
02.09.26
02.09.26
-5.34%
11.12.25
11.12.25
